Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed. Gecko's ...

In an order posted by the U.S. Court of Appeals for the Federal Circuit, the court affirmed a win for Amneal Pharmaceuticals (AMRX) in a decision that would remove patents related to Teva ...

At MEDinIsrael 2019 this week, a conference in Tel Aviv sponsored by the Israeli Export Institute, Dr. Lena Granovsky, director of analytics and big data at Teva Pharmaceuticals, spoke on and off ...

Press releases are posted on Independent.com as a free community service. PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) — Teva Pharmaceuticals, Inc., a U.S ...

With the backing of the U.S. Federal Trade Commission, Amneal convinced a New Jersey federal court on Monday to remove five Teva Pharmaceutical patents from a Food and Drug Administration list of ...

While certain other drugmakers have relented in the face of the U.S. Federal Trade Commission’s (FTC’s) assault on alleged “junk” patents in the FDA’s Orange Book, Teva has largely stood its ground.

Last week, the FTC issued a civil investigative demand, effectively a subpoena, to Teva. This demand compels the company to provide internal communications, analysis, and financial data related to the ...

The FTC has begun an investigation of Teva Pharmaceutical (NYSE:TEVA) over its apparent refusal to withdraw patents related to its asthma and COPD inhalers that the agency argues is delaying generic ...

PARSIPPANY, N.J., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), announced today the launch of a new ...